You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

ERGAMISOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Ergamisol, and when can generic versions of Ergamisol launch?

Ergamisol is a drug marketed by Janssen Pharma and is included in one NDA.

The generic ingredient in ERGAMISOL is levamisole hydrochloride. There are three drug master file entries for this compound. Additional details are available on the levamisole hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ERGAMISOL?
  • What are the global sales for ERGAMISOL?
  • What is Average Wholesale Price for ERGAMISOL?
Summary for ERGAMISOL
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 106
Patent Applications: 5,709
DailyMed Link:ERGAMISOL at DailyMed
Drug patent expirations by year for ERGAMISOL

US Patents and Regulatory Information for ERGAMISOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharma ERGAMISOL levamisole hydrochloride TABLET;ORAL 020035-001 Jun 18, 1990 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ERGAMISOL

See the table below for patents covering ERGAMISOL around the world.

Country Patent Number Title Estimated Expiration
Philippines 9277 METHOD OF AIDING THE REGRESSION OF NEOPLASTIC DISEASE WITH 2,3,5,6-TETRAHYDRO-6-PHENYLIMIDAZO(2,1-B)THIAZOLE ⤷  Sign Up
Australia 5910573 ⤷  Sign Up
France 2196172 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.